Point View Wealth Management’s AbbVie ABBV Stock Holding History

Point View Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$1.28M	Buy	11,959 +444	+4%	+$42.7K	0.52%	58
2020 Q3	$1.01M	Buy	11,515 +202	+2%	+$19K	0.48%	65
2020 Q2	$1.11M	Buy	11,313 +3,237	+40%	+$285K	0.53%	58
2020 Q1	$615K	Buy	8,076 +1,667	+26%	+$142K	0.34%	98
2019 Q4	$567K	Buy	6,409 +135	+2%	+$11.2K	0.23%	137
2019 Q3	$475K	Buy	6,274 +1,027	+20%	+$70.4K	0.22%	146
2019 Q2	$382K	Hold	5,247	–	–	0.16%	169
2019 Q1	$423K	Buy	5,247 +38	+0.7%	+$3.11K	0.19%	156
2018 Q4	$480K	Hold	5,209	–	–	0.24%	131
2018 Q3	$493K	Hold	5,209	–	–	0.22%	147
2018 Q2	$483K	Sell	5,209 -150	-3%	-$14.6K	0.22%	145
2018 Q1	$507K	Buy	5,359 +332	+7%	+$36.5K	0.24%	136
2017 Q4	$486K	Sell	5,027 -23	-0.5%	-$2.17K	0.23%	144
2017 Q3	$449K	Buy	5,050 +50	+1%	+$3.81K	0.22%	150
2017 Q2	$363K	Buy	5,000 +117	+2%	+$7.87K	0.18%	161
2017 Q1	$318K	Buy	4,883 +428	+10%	+$26.9K	0.16%	170
2016 Q4	$279K	Buy	+4,455	New	+$272K	0.16%	173
2016 Q3	–	Sell	-4,455	Closed	-$276K	–	239
2016 Q2	$276K	Hold	4,455	–	–	0.17%	172
2016 Q1	$254K	Buy	+4,455	New	+$248K	0.16%	174

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point View Wealth Management's ABBV Position: Q4 2020 in Review

Point View Wealth Management increased its AbbVie (ABBV) stake by 3.9% in Q4 2020, buying an estimated $42.7K and bringing the position to 11,959 shares worth $1.28M. The position accounts for 0.52% of the portfolio, ranked #58.

Point View Wealth Management first reported a position in ABBV in Q1 2016 and has held it in 19 quarters since. 2,598 funds tracked by Wall St. Rank hold ABBV as of Q4 2020.

Point View Wealth Management held 11,959 shares of AbbVie worth $1.28M as of Q4 2020.
Point View Wealth Management bought 444 AbbVie shares in Q4 2020, an estimated $42.7K.
AbbVie made up 0.52% of Point View Wealth Management's portfolio in Q4 2020, its #58 holding.
Point View Wealth Management first reported a position in AbbVie in Q1 2016 and has held it in 19 quarters since.
2,598 funds tracked by Wall St. Rank held AbbVie as of Q4 2020.

Based on Point View Wealth Management's 13F filing for Q4 2020, filed 8 Feb 2021.